|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Buchbeitrag
Anzahl der Publikationen: 11
Zeitschriftenartikel
Chou, Jinjiang; Kaller, Markus; Jaeckel, Stephanie; Rokavec, Matjaz und Hermeking, Heiko
(27. Mai 2022):
AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p.
In: Molecular Cancer, Bd. 21
[PDF, 13MB]
Liu, Fangteng; Bouznad, Nassim; Kaller, Markus; Shi, Xiaolong; König, Janine; Jaeckel, Stephanie und Hermeking, Heiko
(2022):
Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a.
In: International Journal of Biological Sciences, Bd. 18, Nr. 14: S. 5415-5437
[PDF, 6MB]
Wirth, Anna-Katharina; Wange, Lucas; Vosberg, Sebastian; Henrich, Kai-Oliver; Rausch, Christian; Oezdemir, Erbey; Zeller, Christina M.; Richter, Daniel; Feuchtinger, Tobias; Kaller, Markus; Hermeking, Heiko; Greif, Philipp A.; Senft, Daniela; Jurinovic, Vindi; Bahrami, Ehsan; Jayavelu, Ashok Kumar; Westermann, Frank; Mann, Matthias; Enard, Wolfgang; Herold, Tobias und Jeremias, Irmela
(2022):
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
In: Leukemia, Bd. 36: S. 2863-2874
Shi, Xiaolong; Kaller, Markus; Rokavec, Matjaz; Kirchner, Thomas; Horst, David und Hermeking, Heiko
(2020):
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
In: Cellular and Molecular Gastroenterology and Hepatology, Bd. 10, Nr. 2: S. 391-418
Lamprecht, Sebastian; Kaller, Markus; Schmidt, Eva Marina; Blaj, Cristina; Schiergens, Tobias S.; Engel, Jutta; Jung, Andreas; Hermeking, Heiko; Grünewald, Thomas G. P.; Kirchner, Thomas und Horst, David
(2018):
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer.
In: Clinical cancer research, Bd. 24, Nr. 8: S. 1974-1986
Jaeckel, Stephanie; Kaller, Markus; Jackstadt, Rene; Götz, Ursula; Müller, Susanna; Boos, Sophie; Horst, David; Jung, Peter und Hermeking, Heiko
(2018):
Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
In: Nature Communications, Bd. 9, 3573
[PDF, 3MB]
Oener, Meryem Guelfem; Rokavec, Matjaz; Kaller, Markus; Bouznad, Nassim; Horst, David; Kirchner, Thomas und Hermeking, Heiko
(2018):
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
In: Gastroenterology, Bd. 155, Nr. 6: S. 1868-1882
Rokavec, Matjaz; Kaller, Markus; Horst, David und Hermeking, Heiko
(2017):
Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.
In: Scientific Reports, Bd. 7, 4687
[PDF, 6MB]
Buchbeitrag
Kaller, Markus; Hünten, Sabine; Siemens, Helge und Hermeking, Heiko
(2022):
Analysis of the p53/microRNA Network in Cancer.
In: Schmitz, Ulf; Wolkenhauer, Olaf und Vera-González, Julio (Hrsg.):
Systems Biology of MicroRNAs in Cancer. Advances in Experimental Medicine and Biology, Bd. 1385. Cham: Springer. S. 187-228
Jackstadt, Rene; Kaller, Markus; Menssen, Antje und Hermeking, Heiko
(2021):
Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.
In: Soucek, Laura und Whitfield, Jonathan (Hrsg.):
The Myc Gene. Methods in Molecular Biology, Bd. 2318. S. 119-160
Kaller, Markus und Hermeking, Heiko
(2016):
Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
In: Slaby, Ondrej und Calin, George A. (Hrsg.):
Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology, Bd. 937. Cham: Springer. S. 71-92